Japan's IP High Court is advocating new rules on when patent term extensions for pharmaceuticals should be granted. Shintaro Yamada of Shiga International Patent Office explains what they mean in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback